Recent cross species transmission of avian influenza has highlighted the threat of pandemic
influenza. Oseltamivir (Tamiflu®) has been shown to be effective in the treatment and …

The ongoing threat of seasonal and pandemic influenza to human health requires antivirals
that can effectively supplement existing vaccination strategies. The M2 protein of influenza A …

Abstract In March and early April 2009, a new swine-origin influenza A (H1N1) virus (S-OIV)
emerged in Mexico and the United States. During the first few weeks of surveillance, the …

A highly pathogenic avian influenza virus, H5N1, caused disease outbreaks in poultry in
China and seven other east Asian countries between late 2003 and early 2004; the same …

The dire need for COVID-19 treatments has inspired strategies of repurposing approved
drugs. Amantadine has been suggested as a candidate, and cellular as well as clinical …

Preparedness for a possible influenza pandemic caused by highly pathogenic avian
influenza A subtype H5N1 has become a global priority. The spread of the virus to Europe …

Infection with avian influenza A virus of the H5N1 subtype (isolates A/HK/212/03 and
A/HK/213/03) was fatal to one of two members of a family in southern China in 2003. This …

The development of highly pathogenic avian H5N1 influenza viruses in poultry in Eurasia
accompanied with the increase in human infection in 2006 suggests that the virus has not …

Due to its rapid spread and association with the numerous outbreaks, the global spread of
East Asian lineage of Mycobacterium tuberculosis strains presents a global concern …

We examined the distribution of genetic mutations associated with resistance to the M2 ion
channel–blocking adamantane derivatives, amantadine and rimantadine, among H5N1 …